Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ACTINIUM-PHARMACEUTICALS--16113719/news/Actinium-Pharmaceuticals-Inc-Reports-67-Overall-Response-Rate-in-First-Cohort-in-Actimab-A-Veneto-33592089/?utm_source=whatsapp&utm_medium=social&utm_campaign=share